Recently, it was speculated that the drug might have a therapeutic effect on Crohn’s disease, as TNFSF11 was found to be significantly associated with Crohn’s disease in GWASs.106 The current drugs that are available for the treatment of osteoporosis and their most likely targets are listed in Table 3. This evidence concerns the gene TNFSF11 and osteoporosis.